Vyaire Medical's wind-down has paid $26.4 million of administrative and priority claims and nothing to unsecured creditors
ElevenFlo ·
Vyaire's liquidating plan has been effective since November 27, 2024. Plan administrator David M. Barse reports $26.4 million paid through September 30, 2026, all of it on administrative and priority claims and none on general unsecured claims Dkt. 1168. The open dispute is a lien claim by former coverage counsel Covington & Burling and Reed Smith on a settled insurance recovery. The estate's answer ranks that claim behind the DIP lenders' liens, and mediation is due by December 21, 2026 Dkt. 43.
Jump to section
Vyaire sold its ventilation business to ZOLL and its respiratory diagnostics business to Trudell in 2024 and is winding down under a liquidating plan. The open contest is a suit by its former coverage counsel, who claim a lien on the proceeds of a settled insurance action.
The court confirmed the debtors' second amended liquidating plan on November 14, 2024 Dkt. 745. The plan reached effectiveness on November 27, 2024 Dkt. 810. A final decree entered January 24, 2025 closed 27 affiliate cases. It kept the lead case, No. 24-11217, open under plan administrator David M. Barse, and later motions and adversary proceedings involving any debtor must be filed there Dkt. 974. Barse's report for the quarter ended September 30, 2026 shows $8,502 disbursed in the quarter and $26,428,134 since effectiveness. All of it went to administrative and priority claims, each paid at its allowed amount. Secured claims, general unsecured claims and equity interests show nothing allowed and nothing paid Dkt. 1168.
The one contested matter left is a fight over an insurance recovery. Covington & Burling LLP and Reed Smith LLP represented Vyaire in an insurance coverage action and later withdrew. On November 3, 2025 they filed adversary proceeding 25-52381, asserting claims for declaratory judgment, breach of contract and conversion. The defendants are the wind-down debtors Vyaire Medical, Inc. and Vyaire Holding Co., Barse as plan administrator, and a John Doe liquidating trust Dkt. 1. The defendants deny that the firms hold an attorneys' lien and plead that the DIP lenders' liens are superior Dkt. 43. On October 23, 2026 the court entered a second amended scheduling order on the parties' joint proposal Dkt. 54. The answer's docket entry, filed before that order, lists mediation as due December 21, 2026.
Former coverage counsel claim a fee lien on the insurance settlement, and the estate says the DIP liens come first
The firms' account comes from press coverage of the complaint. On November 4, 2025, Bloomberg Law reported the complaint's allegations. According to the firms, Vyaire settled the coverage case with its product recall insurers in June for an undisclosed amount, without the firms' knowledge or involvement. The firms say they had spent millions representing Vyaire under contingency fee arrangements and that Vyaire "refused to negotiate or even discuss, much less pay, the amounts owed" news.bloomberglaw.com: Vyaire Medical Sued by Covington, Reed Smith Over Unpaid Legal ... (outside source). Law360 described the suit as a claim over lost fees against the company and its plan administrator law360.com: Covington, Reed Smith Sue Vyaire Over Lost Fees - Law360 (outside source).
The defendants answered on August 21, 2026. The answer admits or partially admits some of the engagement, bankruptcy, docket and settlement allegations. It denies that the firms hold an attorneys' lien, that their rights are superior to the DIP lenders' liens, and that they are entitled to payment from the coverage action's proceeds. It alleges that the representation was incompetent, delayed the coverage action, produced no meaningful settlement progress and forced Vyaire to hire replacement counsel and professionals. According to the answer, the firms sought a 40% contingency fee and litigation funding that would have required the debtors to pay at least $2.4 million and up to $4 million on an $800,000 loan. Vyaire had already funded more than $1 million of representation costs. The answer says Marsh Advisory, Cohen Ziffer and the plan administrator resolved the coverage action less than two months after the firms withdrew Dkt. 43.
The defendants plead lack of competence, bad faith, failure of benefit, unclean hands and the DIP lenders' superior liens as defenses. The answer incorporates a motion to dismiss Count II that was pending when it was filed. It asks the court to enter judgment for the defendants on all counts, dismiss the adversary proceeding and sustain the defendants' objections to the firms' proofs of claim Dkt. 43. The dispute therefore turns on two questions. The first is whether the firms hold a lien that reaches the settlement proceeds ahead of the DIP lenders. The second is whether, without a lien, they hold any allowable claim against the estate.
The parties exchanged discovery through the summer and fall of 2026. The defendants served interrogatory responses on July 29, 2026 Dkt. 44. On August 10, 2026, Covington & Burling served a document production Bates-numbered CB_ADPROC_00000001 through CB_ADPROC_00030446 Dkt. 41. The firms noticed four depositions: Joel Amico for October 14 Dkt. 48; John Bibb, the group chief executive who signed Vyaire's first-day declaration, for October 22 Dkt. 50; David Yesh for October 26 Dkt. 49; and Barse for October 27, 2026 Dkt. 47.
Unsecured creditors were released without distribution except through a pool for small scheduled claims
The confirmed second amended plan explains the payment record Dkt. 719. Secured tax claims, other secured claims and other priority claims were unimpaired. First-lien and second-lien claims were impaired. They were entitled to pro rata shares of distributable value after payment of DIP claims and senior classes. Equity interests were cancelled with no distribution, and section 510(b) claims received nothing. A plan administrator replaced the directors and officers. The plan provides for a liquidating trust with a five-year term unless the court extends it.
The confirmation order releases most Class 6 general unsecured claims with no distribution Dkt. 745. The exception covers scheduled, non-contingent, non-disputed claims of $500,000 or less, or claims voluntarily reduced to that threshold. Those claims share in a Residual GUC Recovery Pool. The same order records a settlement among the debtors, the Official Committee of Unsecured Creditors and the required DIP lenders. It included:
- a Residual Claims Recovery Pool and the Residual GUC Recovery Pool;
- at least $3,054,577 for an administrative claims reserve;
- released preference actions;
- funding obligations tied to the ZOLL and Trudell transactions.
The pool came after the first plan. The initial plan, filed September 11, 2024, gave general unsecured claims nothing and cancelled equity Dkt. 518. The committee reserved its rights on the disclosure statement motion Dkt. 578. The amended disclosure statement filed September 30 noted the committee's concerns about the scope of the releases Dkt. 582. The amended plan filed the same day capped the wind-down budget at $25.1 million Dkt. 581. The second amended plan followed on November 11, and the court confirmed it after both sales had closed law360.com: plan was approved after the sales closed (outside source). Cole Schotz made the same point in its confirmation summary coleschotz.com: Cole Schotz's confirmation summary (outside source). The U.S. Trustee objected on two grounds. It argued that liquidating corporate debtors cannot receive a discharge under section 1141(d)(3). It also argued that the released-party definition risked a "creeping discharge" Dkt. 705. The confirmation order overruled unresolved objections Dkt. 745.
Payments since effectiveness follow that order of priority. The notice of effective date fixed an administrative claims bar date of December 27, 2024 and a professional fee application deadline of January 27, 2025 Dkt. 810. The report counts only disbursements made after effectiveness.
| Claim category | Allowed | Paid since effectiveness |
|---|---|---|
| Administrative claims | $26,316,102 | $26,316,102 |
| Priority claims | $112,032 | $112,032 |
| Secured claims | $0 | $0 |
| General unsecured claims | $0 | $0 |
| Equity interests | $0 | $0 |
| Total disbursements | $26,428,134 |
The same report lists $40,875,830 of preconfirmation bankruptcy professional fees and expenses and $205,690 of nonbankruptcy professional fees, all shown as paid Dkt. 1168. Three final applications stand out:
ZOLL bought the ventilation business and Trudell the respiratory diagnostics business, both closing by November 12, 2024
The DIP milestones set a fast track:
- July 1, 2024: qualifying indications of interest and a stalking horse;
- July 22: bids;
- July 25: auction;
- July 29: sale orders;
- August 19: closings.
If qualifying bids did not arrive, the debtors were to end the sale process and wind down under a plan consistent with the restructuring support agreement Dkt. 12. The court entered the bidding procedures order on July 11, 2024 Dkt. 249, the same day as the final DIP order. The sales ran behind those dates and split the company in two.
| Buyer | Business | Sale order | Closed | Consideration in the filings |
|---|---|---|---|---|
| ZOLL Medical Corporation | Ventilation | September 4, 2024 Dkt. 496 | October 11, 2024 Dkt. 626 | Approximately $37 million in the amended disclosure statement Dkt. 582. The amended purchase agreement provided a $45,791,471.50 cash payment, a $7.9 million MIM cash payment and assumed liabilities, including a $5 million cure-cost cap Dkt. 626. |
| Trudell Medical Limited | Respiratory diagnostics | September 4, 2024 Dkt. 497 | November 12, 2024 Dkt. 736 | $53.5 million in the amended disclosure statement Dkt. 582 |
The ZOLL terms changed before closing. On October 8, 2024, the committee filed an emergency motion saying that material amendments to the ZOLL sale documents had not been filed publicly. It questioned whether the estates would remain administratively solvent if the closing slipped or the economics changed Dkt. 611. The sale closed three days later on the amended terms Dkt. 626. On October 15, 2024, the court approved a stipulation with SunMed Group Holdings, LLC (d/b/a AirLife) in connection with the ZOLL sale Dkt. 632. Vyaire said it had completed both business-unit sales medicaldesigndevelopment.com: Vyaire Medical - Sales Completion (outside source).
First-lien lenders funded the case with $45 million of new money and a $135 million roll-up
The first-lien lenders were the only practical source of new money. The DIP motion sought a $180 million facility: $45 million of new-money commitments and a roll-up of up to $135 million of first-lien term loans Dkt. 12. According to a supporting declaration, the debtors approached six financial institutions and received proposals from the sponsor and the second-lien lenders. The first-lien lenders would not consent to a priming facility from a third party, and the debtors had no unencumbered assets to offer Dkt. 44. Pachulski Stang Ziehl & Jones represented the first-lien ad hoc group. The firm describes the group as holding more than $400 million of first-lien debt and as having negotiated the prepetition restructuring support agreement with certain second-lien lenders, with a sale of substantially all assets in view pszjlaw.com: Vyaire Medical, Inc. (outside source).
The interim DIP order, entered June 12, 2024, made $25 million of new money available at once and placed $20 million in escrow Dkt. 103. It deemed $75 million of first-lien term loans rolled up. Each new-money dollar withdrawn later allowed up to three more dollars of term loans to roll up. Contemporaneous coverage reported that Vyaire could tap the initial $25 million tranche law360.com: Law360 - DIP Approval (outside source). The final DIP order followed on July 11, 2024 Dkt. 248. The facility matured at the earliest of several events, including a sale of substantially all assets, October 10, 2024 and plan consummation Dkt. 103.
The final order added lender protections that the interim order did not contain. The estates waived surcharge under section 506(c), the section 552(b) equities-of-the-case exception and marshaling. DIP liens reached the proceeds of avoidance actions. Parties with standing had until August 26, 2024 to challenge prepetition liens and claims, with a $125,000 investigation budget Dkt. 248. The first plan, filed in September 2024, put the DIP at $37.5 million of new-money loans and $135 million of roll-up loans. It tied a DIP paydown to $56 million of cash sale proceeds Dkt. 518. The DIP ended at plan effectiveness on November 27, 2024.
Vyaire entered chapter 11 with about $533.6 million of secured funded debt
The first-day declaration reports approximately $533.6 million of funded debt at the petition date, all of it secured. That total comprises $417.9 million of first-lien debt and a $115.7 million second-lien term loan Dkt. 15 · p. 18.
- First lien
- Second lien
- First-lien term loanBank of America, N.A. · April 16, 2025$339.3M
- First-lien notesWilmington Trust, N.A. · April 16, 2025$78.6M
- Second-lien term loanWilmington Trust, N.A. · April 16, 2026$115.7M
Total$533.6M
Show the numbers
| Debt | Agent | Maturity | Principal |
|---|---|---|---|
| First-lien term loan | Bank of America, N.A. | April 16, 2025 | $339.3M |
| First-lien notes | Wilmington Trust, N.A. | April 16, 2025 | $78.6M |
| Second-lien term loan | Wilmington Trust, N.A. | April 16, 2026 | $115.7M |
| Total | $533.6M |
Source: first-day declaration Dkt. 15 · p. 18
The first-lien term loan carried interest at SOFR plus 4.75%, or 10.1% as of May 17, 2024. It was secured by first-priority liens on all or substantially all assets of Vyaire Medical, Inc. and its guarantors Dkt. 15 · p. 19. The first-lien notes were issued under a May 3, 2019 note purchase agreement. They carried EURIBOR plus 4.75%, or 8.5%, and shared the first-lien collateral. The second-lien term loan carried EURIBOR plus 8.25%, or 12.08%. Amendments made between November 2018 and May 2023 allowed payment-in-kind interest on it Dkt. 15 · p. 20.
The final DIP order states the first-lien notes at €72,102,348.98 of principal at the petition date Dkt. 248 · p. 11. The DIP motion states the second-lien term loans at €106,178,070.76 Dkt. 12 · p. 61. The roll-up later reduced the prepetition first-lien term loan. The second amended plan defines it at $204.3 million currently outstanding Dkt. 719 · p. 15. That figure is the $339.3 million petition-date balance less the $135 million moved into the DIP.
Pandemic ventilator demand reversed and a refinancing failed
Vyaire Medical, Inc. and 27 affiliates filed in Delaware on June 9, 2024 Dkt. 1. The first-day declaration describes a global ventilation and respiratory diagnostics company headquartered in Mettawa, Illinois. It was majority-owned by funds advised by Apax Partners LP, had about 950 full-time employees and sold products in more than 100 countries Dkt. 15. COVID-era demand inflated the ventilation business. The amended disclosure statement puts ventilation revenue at $215 million in 2019 and $620 million in 2020, falling to $163 million by 2023 Dkt. 582. The declaration adds that Vyaire lost more than 10% market share in sub-acute ventilation between 2021 and 2022. Ventilation revenue fell 20% in early 2024 while respiratory diagnostics grew 5% to 10%, and below-plan results in the first half of the fiscal year frustrated efforts to refinance. Single-source suppliers, supply-chain disruption and an overhead structure built for pandemic volumes added to the pressure Dkt. 15.
An earlier sale did not close the gap. Vyaire sold its consumables business in May 2023 for approximately $310 million, netting $133.9 million after paying down debt Dkt. 15. Out-of-court talks with its secured lenders failed, and in April 2024 it sought bridge financing from them Dkt. 44. A marketing process began the same month. PJT Partners contacted more than 110 potential partners, and more than 30 had signed nondisclosure agreements by the petition date. A majority of the first-lien lenders, certain second-lien lenders and Apax supported the filing under a restructuring support agreement Dkt. 15. S&P Global's coverage described the same post-COVID demand reset and sponsor-backed agreement spglobal.com: Vyaire Medical Inc. Downgraded To 'D' From 'CCC' (outside source).
Sources
- Dkt. 1Adversary case 25-52381. Complaint // Adversary Complaint for Declaratory Judgment, Breach of Contract, Conversion, and Related Relief by Covington & Burling LLP, Reed Smith LLP against VYAIRE MEDICAL, INC. and VYAIRE HOLDING CO., as WIND-DOWN DEBTORS, DAVID M. BARSE, in his capacity as Plan Administrator of Vyaire Medical, Inc., JOHN DOE LIQUIDATING TRUST. Fee Amount $350 (91 (Declaratory judgment)). AP Summons Served due date: 2/4/2026. (Rosner, Frederick) (Entered: 11/03/2025)Filed Nov 3, 2025Nov 3, 2025
- Dkt. 1Chapter 11 Voluntary Petition . Fee Amount $1738. Filed by Vyaire Medical, Inc.. (Reilley, Patrick) (Entered: 06/09/2024)Filed Jun 9, 2024Jun 9, 2024
- Dkt. 12Motion to Approve Debtor In Possession Financing Filed By Vyaire Medical, Inc. (Reilley, Patrick)Cited at p. 61 · Filed Jun 10, 2024Jun 10, 2024
- Dkt. 15First Day DeclarationFiled Jun 10, 2024Jun 10, 2024
- Dkt. 41Production Service NoticeFiled Aug 12, 2026Aug 12, 2026
- Dkt. 43Answer and Affirmative DefensesFiled Aug 21, 2026Aug 21, 2026
- Dkt. 44Discovery Service NoticeFiled Aug 21, 2026Aug 21, 2026
- Dkt. 44DIP / Cash Collateral DeclarationFiled Jun 10, 2024Jun 10, 2024
- Dkt. 47Barse Deposition NoticeFiled Sep 25, 2026Sep 25, 2026
- Dkt. 48Amico Deposition NoticeFiled Sep 25, 2026Sep 25, 2026
- Dkt. 49Yesh Deposition NoticeFiled Sep 29, 2026Sep 29, 2026
- Dkt. 50Bibb Deposition NoticeFiled Oct 5, 2026Oct 5, 2026
- Dkt. 54Second Amended Scheduling OrderFiled Oct 23, 2026Oct 23, 2026
- Dkt. 103DIP / Cash Collateral Order (Interim)Filed Jun 12, 2024Jun 12, 2024
- Dkt. 248Final Order (I) Authorizing the Debtors to (A) Obtain Postpetition Financing and (B) Utilize Cash Collateral, (II) Granting Liens and Superpriority Administrative Expense Claims, (III) Granting Adequate Protection to Prepetition Secured Parties, (IV) Modifying the Automatic Stay, (V) Scheduling a Final Hearing, and (VI) Granting Related Relief (related document(s)[12], [232]) Order Signed on 7/11/2024. (JMW)Cited at p. 11 · Filed Jul 11, 2024Jul 11, 2024
- Dkt. 249Order (I) Approving Bidding Procedures in Connection with the Sale of Substantially All of The Debtors' Assets, (II) Authorizing The Debtors to Enter into a Stalking Horse Agreement and Provide Bid Protections, (III) Approving the Form and Manner of Notice Thereof, (IV) Scheduling an Auction and Sale Hearing, (V) Approving Procedures for the Assumption and Assignment of Contracts, (VI) Approving the Sale of The Debtors' Assets Free and Clear, and (VII) Granting Related Relief (Related Doc # [16] ... moreFiled Jul 11, 2024Jul 11, 2024
- Dkt. 496Sale OrderFiled Sep 4, 2024Sep 4, 2024
- Dkt. 497Sale OrderFiled Sep 4, 2024Sep 4, 2024
- Dkt. 518Chapter 11 PlanFiled Sep 11, 2024Sep 11, 2024
- Dkt. 578Reservation of Rights Regarding the Motion of Debtors for Entry of an Order (I) Approving the Adequacy of the Disclosure Statement on an Interim and Final Basis; (II) Scheduling a Combined Disclosure Statement and Plan Confirmation Hearing, (III) Approving the Solicitation and Notice Procedures, (IV) Approving the Combined Hearing Notice, and (V) Granting Related Relief (related document(s)[518], [519], [520], [521]) Filed by The Official Committee of Unsecured Creditors of Vyaire Medical, Inc., ... moreFiled Sep 27, 2024Sep 27, 2024
- Dkt. 581Chapter 11 PlanFiled Sep 30, 2024Sep 30, 2024
- Dkt. 582Disclosure StatementFiled Sep 30, 2024Sep 30, 2024
- Dkt. 611Motion to Approve // Emergency Motion of the Official Committee of Unsecured Creditors Requesting a Status Conference Regarding the Zoll Sale Order and Asset Purchase Agreement (related document(s)[496]) Filed by The Official Committee of Unsecured Creditors of Vyaire Medical, Inc., et al.. (Attachments: # (1) Exhibit A # (2) Certificate of Service) (Kandestin, Maris)Filed Oct 8, 2024Oct 8, 2024
- Dkt. 626Exhibit(s) / Notice of Closing of Sale of Certain of the Debtors' Ventilation Assets to Zoll Medical Corp. (related document(s)[249], [388], [496], [614]) Filed by Vyaire Medical, Inc.. (Attachments: # (1) Exhibit 1) (Reilley, Patrick)Filed Oct 11, 2024Oct 11, 2024
- Dkt. 632Order Approving Joint Stipulation Between the Debtors and Sunmed Group Holdings, LLC (d/b/a Airlife) in Connection with Zoll Sale (related document(s)[249], [388], [496], [631]) Order Signed on 10/15/2024. (Attachments: # (1) Exhibit 1) (JMW)Filed Oct 15, 2024Oct 15, 2024
- Dkt. 705Limited Objection to Confirmation of Plan (related document(s)[581]) Filed by U.S. Trustee (related document(s)[581]). (Attachments: # (1) Certificate of Service)(Hackman, Benjamin)Filed Nov 4, 2024Nov 4, 2024
- Dkt. 719Chapter 11 PlanCited at p. 15 · Filed Nov 11, 2024Nov 11, 2024
- Dkt. 736Exhibit(s) / Notice of Closing of Sale of Certain of the Debtors' Respiratory Diagnostics Assets to Trudell Medical Limited (related document(s)[249], [400], [497], [711]) Filed by Vyaire Medical, Inc.. (Attachments: # (1) Exhibit 1) (Reilley, Patrick)Filed Nov 13, 2024Nov 13, 2024
- Dkt. 745Findings of Fact and Conclusions of Law, and Order Approving The Debtors' Disclosure Statement for, and Confirming the Second Amended Joint Plan of Vyaire Medical, Inc. and Its Debtor Affiliates. (related document(s)[518], [581], [719]) Signed on 11/14/2024. (Attachments: # (1) Exhibit A # (2) Exhibit B) (JMW)Filed Nov 14, 2024Nov 14, 2024
- Dkt. 795Application for Compensation (Application of AP Services, LLC for Approval of Completion Fee) for the period to (related document(s)[338]) Filed by Vyaire Medical, Inc.. Hearing scheduled for 1/29/2025 at 10:30 AM at US Bankruptcy Court, 824 Market St., 6th Fl., Courtroom #1, Wilmington, Delaware. Objections due by 12/13/2024. (Attachments: # (1) Notice of Application # (2) Exhibit A - Engagement Letter # (3) Exhibit B - Declaration of Charles Braley # (4) Exhibit C - Proposed Order) (Reilley, ... moreFiled Nov 22, 2024Nov 22, 2024
- Dkt. 810Notice of Effective Date (Notice of (I) Entry of Confirmation Order, (II) Occurrence of Effective Date, and (III) Related Bar Dates) (related document(s)[719], [745]) Filed by Vyaire Medical, Inc.. (Reilley, Patrick)Filed Nov 27, 2024Nov 27, 2024
- Dkt. 882Final Application for Compensation / Second Interim and Final Fee Application of Kirkland & Ellis LLP and Kirkland & Ellis International LLP, Attorneys for the Debtors and Debtors in Possession, for the (I) Interim Fee Period from September 1, 2024, Through and Including November 14, 2024, and the (II) Final Fee Period for the period June 9, 2024 to November 14, 2024 Filed by Vyaire Medical, Inc.. Hearing scheduled for 1/29/2025 at 10:30 AM at US Bankruptcy Court, 824 Market St., 6th Fl., Courtr ... moreFiled Dec 23, 2024Dec 23, 2024
- Dkt. 883Final Application for Compensation / Second Interim and Final Fee Application of PJT Partners LP as Investment Banker to the Debtors and Debtors in Possession for Allowance (and Final Approval) of Compensation for Services Rendered and For the Reimbursement of All Actual and Necessary Expenses Incurred for the period June 9, 2024 to November 14, 2024 Filed by Vyaire Medical, Inc.. Hearing scheduled for 1/29/2025 at 10:30 AM at US Bankruptcy Court, 824 Market St., 6th Fl., Courtroom #1, Wilmingto ... moreFiled Dec 23, 2024Dec 23, 2024
- Dkt. 974Final Decree Closing Affiliate CasesFiled Jan 24, 2025Jan 24, 2025
- Dkt. 1168Post-Confirmation ReportFiled Oct 13, 2026Oct 13, 2026
- WebVyaire Medical Sued by Covington, Reed Smith Over Unpaid Legal ...news.bloomberglaw.com · Outside source
- WebCovington, Reed Smith Sue Vyaire Over Lost Fees - Law360law360.com · Outside source
- Webplan was approved after the sales closedlaw360.com · Outside source
- WebCole Schotz's confirmation summarycoleschotz.com · Outside source
- WebVyaire Medical - Sales Completionmedicaldesigndevelopment.com · Outside source
- WebVyaire Medical, Inc.pszjlaw.com · Outside source
- WebLaw360 - DIP Approvallaw360.com · Outside source
- WebVyaire Medical Inc. Downgraded To 'D' From 'CCC'spglobal.com · Outside source